EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual P&L / Income Statement
2025-01-01 to 2025-12-31
Revenue by Business Segment
2025-01-01 to 2025-12-31
Swipe to see the full flow
Chart details
EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual P&L / Income Statement
Income statement for 2025-01-01 through 2025-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Net sales
- 6,067,600,000 US dollars
- Cost of sales
- 1,334,200,000 US dollars
- Gross profit
- 4,733,400,000 US dollars
- Operating costs, net of other operating income (calculated)
- 3,469,200,000 US dollars
- Operating income
- 1,264,200,000 US dollars
- Other income (expense), net (calculated)
- 8,700,000 US dollars
- Income from continuing operations before provision for income taxes
- 1,272,900,000 US dollars
- Provision for income taxes (Note 19)
- 216,900,000 US dollars
- Net income
- 1,069,400,000 US dollars
- United States
- 3,543,100,000 US dollars
- Europe
- 1,517,500,000 US dollars
- Japan
- 354,700,000 US dollars
- Rest of World
- 652,300,000 US dollars
- Selling, general, and administrative expenses
- 2,085,200,000 US dollars
- Research and development expenses
- 1,079,200,000 US dollars
- Intellectual property agreement and certain litigation expenses (Note 3)
- 325,400,000 US dollars
- Change in fair value of contingent consideration liabilities (Note 13)
- negative 12,500,000 US dollars
- Restructuring charges, separation costs, and other (Note 4)
- 19,100,000 US dollars
- Intangible assets impairment charges
- 40,000,000 US dollars
- Other operating income
- negative 67,200,000 US dollars
- Income from discontinued operations, net of tax
- 13,400,000 US dollars. Reported below-tax contribution to net income.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $1.07 B; to noncontrolling interests: −$4.10 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
78.0%
Gross profit / revenue
Operating margin
20.8%
Operating profit / revenue
Cash conversion
149.2%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
